Oncolys BioPharma, Tacere deal

Oncolys exercised its option to license Asian rights to develop and commercialize Tacere’s OBP-701 (TT-033)

Read the full 156 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE